25 April 2017 - Deborah Wilkes
Archived
German healthcare company Fresenius has agreed to acquire US generics, OTC and animal health company Akorn in a deal worth approximately USD4.75 billion, including debt.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.